Column Group Opportunity III, LP, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 5,378 shares at $4.95 ($27K) on 2023-01-12, disclosed to the SEC on 2023-01-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |